| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.19B | -11.8% | +2.6% |
| R&D Expense | $22.0M | -8.3% | -12.0% |
| SG&A Expense | $177.0M | +2.3% | -1.1% |
| Operating Income | $348.0M | -17.5% | -5.2% |
| Interest Expense | $66.0M | -2.9% | +0.0% |
| Pre-tax Income | -$155.0M | -169.2% | -204.0% |
| Income Tax | $4.0M | -93.4% | -89.7% |
| Net Income | -$160.0M | -198.2% | -245.5% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $825.0M | -28.7% | +4.3% |
| Inventory | $3.70B | +8.8% | +26.6% |
| Current Assets | $7.15B | +1.1% | +16.9% |
| Total Assets | $18.25B | +3.1% | +17.8% |
| Current Liabilities | $5.61B | +3.9% | +4.3% |
| Long-term Debt | $6.34B | -0.0% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$90.0M | — | — |
| Investing Cash Flow | -$1.55B | — | — |
| Financing Cash Flow | $1.42B | — | — |
| +26.5% |
| Total Liabilities | $12.94B | +0.7% | +13.5% |
| Stockholders' Equity | $5.29B | +9.5% | +29.9% |